BEUDAMED
    FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

    Tricuspid Valve Repair Device, Percutaneously Delivered

    PMA: P230007 · Supplement: S013 · Decision Jun 25, 2025
    View on FDA
    Classifications
    1
    FEI Numbers
    3
    Registration Numbers
    3

    Basic Information

    Device Name
    Tricuspid Valve Repair Device, Percutaneously Delivered
    Trade Name
    TriClip™ G4 Delivery System; MitraClip™ G5 Delivery System, TriClip™ G5 Delivery System
    PMA Number
    P230007
    Supplement Number
    S013
    Device Class
    FDA Class 3
    Product Code
    NPS
    Generic Name
    Tricuspid valve repair device, percutaneously delivered
    Medical Specialty
    Unknown
    Advisory Committee
    Cardiovascular
    Decision
    30-Day Notice Accepted
    Decision Code
    OK30
    Decision Date
    June 25, 2025
    Date Received
    May 27, 2025
    Supplement Type
    30-Day Notice
    Supplement Reason
    Process Change - Manufacturer/Sterilizer/Packager/Supplier
    Expedited Review
    N

    Advisory Committee Statement

    implementation of an alternative measurement system for evaluating the distance between two components of the Sleeve Toggle Subassembly

    Classifications

    This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

    Product Code Device Name
    NPS Tricuspid Valve Repair Device, Percutaneously Delivered